As the US healthcare system transitions from volume to value, there is some concern that while new payment models and reforms may be neither conceptually flawed nor badly designed, the implementation of these reforms may be insufficient to fully achieve any potential success. If we get the architectural plan right but our building materials and methods are flawed, we wind up with a disappointing result.
As the US healthcare system transitions from volume to value, there is some concern that while new payment models and reforms may be neither conceptually flawed nor badly designed, the implementation of these reforms may be insufficient to fully achieve any potential success. If we get the architectural plan right but our building materials and methods are flawed, we wind up with a disappointing result.
Providers are under significant pressure to improve the quality and efficiency of care. They are changing how they relate to one another and to the organizations in which they work, as well as thoroughly rethinking business practices. Making the vision of accountable care a reality is an enormous task and there are so many components and calibrations. Communication is among the most important.
In this June issue of The American Journal of Accountable Care, Drs José A. Pagán and Brendan Saloner note the importance of communication in new payment models in “Do You Speak My Language? When Patient Care Meets Cost-Effectiveness.” They focus on what can sometimes be a disconnect in the terminology that frames reform and point out the need for system translators with fluency in both the language of economics and patient care in order to facilitate the interaction between physicians and health system leaders in order to assure that all stakeholders’ understandings and expectations are aligned. The authors view this type of translation as essential to the widespread adoption of innovation.
The key role of effective organizational communication is also discussed by Lise Rybowski and her coauthors in their article, “Impact of Incentives to Improve Care for Primary Care Patients.” They find that, among other program design issues, a dearth of ongoing communication related to a pay-for-performance program’s purpose, available support and goals and was a major hindrance to successful implementation. Reaching the target audience is key for the success of any incentive, and in this case, many providers charged with care improvement were not adequately informed.
By contrast, successful communication between stakeholders has been a hallmark of both the design and implementation of payment reform in Arkansas, as detailed in “The Arkansas Payment Improvement Initiative: Early Perceptions of Multi-Payer Reform in a Fragmented Provider Landscape.” While the results to date are early ones, the effort of both the state’s public and private sectors to explain the concepts behind the initiative and development of its episodic payment and patient-centered medical home components has been notable. We and our coauthors found there to be a significant degree of “buy-in” and understanding of program goals and incentives. Given the scope of the undertaking and the potential pitfalls detailed elsewhere in this issue, this is no small achievement.
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH
July 30th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The August issue features a conversation with Charles N. (Chip) Kahn III, MPH, the president and CEO of the Federation of American Hospitals and a longtime member of the AJMC editorial board.
Read More
Effects of Adjunctive Cariprazine Formulary Restrictions in Major Depressive Disorder
July 23rd 2025Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved claims.
Read More